Newly discovered trigger of Parkinson's upends common beliefs
A new Northwestern Medicine study challenges a common belief in what triggers Parkinson's disease.
Sep 15, 2023
0
253
A new Northwestern Medicine study challenges a common belief in what triggers Parkinson's disease.
Sep 15, 2023
0
253
Finding the right medication regimen to treat Parkinson's disease (PD) is a complex health care challenge. Wearable health trackers provide physicians with a detailed window into patients' symptoms, but translating this complex ...
Sep 12, 2023
0
7
Parkinson's disease, characterized by various motor dysfunctions, is the second most common neurodegenerative disorder in the world. It is known that specific gene mutations that are passed down through families are responsible ...
Sep 11, 2023
0
28
Even the best treatment approaches for Parkinson's disease are inadequate if they do not address patients' feelings of social rejection, isolation, loneliness and other psychosocial effects of stigma, according to a report ...
Sep 11, 2023
0
1
An artificial intelligence tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study in npj Digital Medicine ...
Sep 7, 2023
0
165
In many neurodegenerative disorders, abnormal proteins progressively aggregate and propagate in the brain. But what comes first, aggregation or propagation? Researchers from Japan share some new insights about the mechanism ...
Sep 7, 2023
0
66
A new paper looking at the causes of death among Australians with type 1 and type 2 diabetes highlights dementia and falls are increasing, while deaths from heart disease are declining.
Sep 1, 2023
0
13
Researchers have developed a blood test that detects Parkinson's disease, potentially establishing a way to help diagnose the condition before nervous system damage worsens.
Aug 30, 2023
0
80
About one in every five people carries a version of a gene that—although largely unsung—appears to confer protection against both Alzheimer's disease and Parkinson's disease, Stanford Medicine investigators and their ...
Aug 30, 2023
0
111
An experimental drug targeting a genetic variant linked to Parkinson's disease had no effect on patients, according to the results of a new clinical trial published in The Lancet Neurology.
Aug 28, 2023
0
42